Calendar Viking Therapeutics, Inc.

Equities

VKTX

US92686J1060

Market Closed - Nasdaq 16:00:00 2024-06-13 EDT 5-day change 1st Jan Change
52.1 USD -0.69% Intraday chart for Viking Therapeutics, Inc. -5.29% +179.96%

Chart calendar Viking Therapeutics, Inc.

ac89.AwX8IwnrwTBvUm4Bh3XbZSg_KecHeVKTEX4RaRdbKMM.dF-7WXGo-QAmDTxvyAONL0x4Q6BUATDiXytoHFUdYKlvUrUXQoz1YVoLIw~d97e10625257d7fce36421d626f3ee0a

Upcoming events on Viking Therapeutics, Inc.

2024-06-24 Stifel European Healthcare Summit
2024-07-23 Q2 2024 Earnings Release (Projected)
2024-10-29 Q3 2024 Earnings Release (Projected)
2025-02-04 Q4 2024 Earnings Release (Projected)
2025-04-22 Q1 2025 Earnings Release (Projected)

Past events on Viking Therapeutics, Inc.

2024-06-06 10:30 Jefferies Global Healthcare Conference
2024-06-04 08:00 VK2809 Phase 2b Study Results Call
2024-05-21 11:00 Annual General Meeting
2024-04-24 16:30 Q1 2024 Earnings Call
2024-04-24 16:05 Q1 2024 Earnings Release
2024-03-26 08:00 VK2735 Phase 1 Trial Results Call
2024-02-27 08:00 VK2735 Phase 2 VENTURE Trial Results Call
2024-02-12 Oppenheimer Healthcare Life Sciences Conference
2024-02-07 16:30 Q4 2023 Earnings Call
2024-02-07 16:05 Q4 2023 Earnings Release
2023-11-28 08:45 Evercore ISI HealthCONx Conference
2023-11-16 07:30 Jefferies London Healthcare Conference
2023-11-14 13:50 Stifel Healthcare Conference
2023-11-07 UBS BioPharma Conference
2023-11-07 Truist Securities BioPharma Symposium
2023-10-25 16:30 Q3 2023 Earnings Call
2023-10-25 16:05 Q3 2023 Earnings Release
2023-10-16 Obesity Week Meeting
2023-09-13 07:30 Morgan Stanley Global Healthcare Conference
2023-09-12 12:30 H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
-32,7
-31,9
-2.47%
-42,7
-41,7
-2.31%
-55,7
-57,7
3.5%
0,00
0,00
-
-101
-100
-0.65%

-141

EBIT
Million USD
Released
Forecast
Spread
-32,7
-34,7
5.93%
-42,7
-43,5
2.01%
-55,7
-58,0
4.03%
-70,4
-68,3
-2.96%
-101
-99,5
-1.31%

-144

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-25,8
-29,4
12.27%
-39,5
-39,8
0.67%
-55,0
-57,2
3.91%
-68,9
-67,4
-2.18%
-85,9
-86,9
1.11%

-120

Net income
Million USD
Released
Forecast
Spread
-25,8
-29,3
12.08%
-39,5
-39,8
0.67%
-55,0
-57,2
3.93%
-68,9
-67,5
-1.97%
-85,9
-86,6
0.85%

-119

EPS
USD
Released
Forecast
Spread
-0,36
-0,41
11.29%
-0,54
-0,55
1.58%
-0,71
-0,74
3.79%
-0,90
-0,88
-2.62%
-0,91
-0,92
1.52%

-1,12

Announcement Date26/02/2017/02/2109/02/2208/02/2307/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBITDA
Million USD
Released
Forecast
Spread
-16,2
-13,9
-16.87%
-17,6
-16,6
-6.21%
-16,2
-17,8
9.01%



-20,5
-19,6
-4.86%
-23,7
-21,1
-12.51%
-27,3
-24,3
-12.43%
-29,3
-28,6
-2.4%
-34,1
-29,6
-15.02%

-33,7


-35,5


-37,5







EBIT
Million USD
Released
Forecast
Spread
-16,2
-14,9
-8.89%
-17,6
-16,7
-5.55%
-16,2
-18,4
12.02%
-20,3
-18,3
-11.11%
-20,5
-19,4
-5.99%
-23,7
-18,6
-27.92%
-27,3
-23,8
-14.67%
-29,3
-27,9
-4.88%
-34,1
-30,6
-11.32%

-35,1


-36,6


-37,8


-48,2


-52,7

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-16,1
-14,6
-10.48%
-17,4
-16,3
-6.7%
-15,8
-18,0
12.48%
-19,6
-17,9
-9.34%
-19,5
-18,7
-4.34%
-19,2
-17,9
-7.57%
-22,5
-21,7
-3.61%
-24,6
-25,6
3.89%
-27,4
-28,6
4.38%

-29,2


-30,8


-32,3


-38,7


-43,4

Net income
Million USD
Released
Forecast
Spread
-16,1
-14,8
-8.75%
-17,4
-16,6
-5.12%
-15,8
-18,1
12.89%
-19,6
-17,9
-9.53%
-19,5
-18,8
-4.04%
-19,2
-18,2
-5.35%
-22,5
-22,0
-2.33%
-24,6
-25,4
3.29%
-27,4
-28,4
3.84%

-28,7


-30,4


-31,9


-38,7


-43,4

EPS
USD
Released
Forecast
Spread
-0,21
-0,19
-9.37%
-0,23
-0,21
-8.49%
-0,21
-0,23
9.87%
-0,26
-0,23
-12.07%
-0,25
-0,24
-4.17%
-0,19
-0,19
1.42%
-0,23
-0,22
-4.98%
-0,25
-0,26
1.96%
-0,26
-0,28
8.23%

-0,27


-0,28


-0,30


-0,31


-0,34

Announcement Date27/04/2227/07/2226/10/2208/02/2326/04/2326/07/2325/10/2307/02/2424/04/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. VKTX Stock
  4. Calendar Viking Therapeutics, Inc.